{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:24:32Z","timestamp":1761708272458},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s11886-008-0060-y","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T03:07:21Z","timestamp":1224040041000},"page":"376-383","source":"Crossref","is-referenced-by-count":39,"title":["Brugada syndrome: Recent advances and controversies"],"prefix":"10.1007","volume":"10","author":[{"given":"Charles","family":"Antzelevitch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Nof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,16]]},"reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","volume":"20","author":"P. Brugada","year":"1992","unstructured":"Brugada P, Brugada J: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 1992, 20:1391\u20131396.","journal-title":"J Am Coll Cardiol"},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/01.RES.69.2.277","volume":"69","author":"S.C. Krishnan","year":"1991","unstructured":"Krishnan SC, Antzelevitch C: Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ Res 1991, 69:277\u2013291.","journal-title":"Circ Res"},{"key":"60_CR3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.87.2.562","volume":"87","author":"S.C. Krishnan","year":"1993","unstructured":"Krishnan SC, Antzelevitch C: Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry? Circulation 1993, 87:562\u2013572.","journal-title":"Circulation"},{"key":"60_CR4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.CIR.93.2.372","volume":"93","author":"G.X. Yan","year":"1996","unstructured":"Yan GX, Antzelevitch C: Cellular basis for the electrocardiographic J wave. Circulation 1996, 93:372\u2013379.","journal-title":"Circulation"},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0735-1097(95)00613-3","volume":"27","author":"T. Miyazaki","year":"1996","unstructured":"Miyazaki T, Mitamura H, Miyoshi S, et al.: Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996, 27:1061\u20131070.","journal-title":"J Am Coll Cardiol"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/01.CIR.0000034169.45752.4A","volume":"106","author":"A.A. Wilde","year":"2002","unstructured":"Wilde AA, Antzelevitch C, Borggrefe M, et al.: Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002, 106:2514\u20132519.","journal-title":"Circulation"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","volume":"111","author":"C. Antzelevitch","year":"2005","unstructured":"Antzelevitch C, Brugada P, Borggrefe M, et al.: Brugada Syndrome. Report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005, 111:659\u2013670.","journal-title":"Circulation"},{"key":"60_CR8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/32675","volume":"392","author":"Q. Chen","year":"1998","unstructured":"Chen Q, Kirsch GE, Zhang D, et al.: Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 1998, 392:293\u2013296.","journal-title":"Nature"},{"key":"60_CR9","doi-asserted-by":"crossref","DOI":"10.1002\/9780470994900","volume-title":"The Brugada Syndrome: From Bench to Bedside","author":"C. Antzelevitch","year":"2005","unstructured":"Antzelevitch C, Brugada P, Brugada J, et al.: The Brugada Syndrome: From Bench to Bedside. Oxford: Blackwell Futura; 2005."},{"issue":"Suppl1","key":"60_CR10","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1111\/j.1540-8167.2006.00398.x","volume":"17","author":"H.L. Tan","year":"2006","unstructured":"Tan HL: Sodium channel variants in heart disease: expanding horizons. J Cardiovasc Electrophysiol 2006, 17(Suppl 1):S151\u2013S157.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.yjmcc.2004.10.015","volume":"38","author":"K. Hong","year":"2005","unstructured":"Hong K, Guerchicoff A, Pollevick GD, et al.: Cryptic 5\u2032 splice site activation in SCN5A associated with Brugada syndrome. J Mol Cell Cardiol 2005, 38:555\u2013560.","journal-title":"J Mol Cell Cardiol"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.105.580811","volume":"113","author":"C.R. Bezzina","year":"2006","unstructured":"Bezzina CR, Shimizu W, Yang P, et al.: Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 2006, 113:338\u2013344.","journal-title":"Circulation"},{"key":"60_CR13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.ejhg.5201952","volume":"16","author":"P. Yang","year":"2008","unstructured":"Yang P, Koopmann TT, Pfeufer A, et al.: Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activity. Eur J Hum Genet 2008, 16:350\u2013357.","journal-title":"Eur J Hum Genet"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1161\/CIRCULATIONAHA.107.703330","volume":"116","author":"B. London","year":"2007","unstructured":"London B, Michalec M, Mehdi H, et al.: Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation 2007, 116:2260\u20132268.","journal-title":"Circulation"},{"key":"60_CR15","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.704627","volume":"116","author":"D.W. Norstrand Van","year":"2007","unstructured":"Van Norstrand DW, Valdivia CR, Tester DJ, et al.: Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 2007, 116:2253\u20132259.","journal-title":"Circulation"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/adc.2004.058115","volume":"90","author":"J.R. Skinner","year":"2005","unstructured":"Skinner JR, Chung SK, Montgomery D, et al.: Near-miss SIDS due to Brugada syndrome. Arch Dis Child 2005, 90:528\u2013529.","journal-title":"Arch Dis Child"},{"key":"60_CR17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","volume":"115","author":"C. Antzelevitch","year":"2007","unstructured":"Antzelevitch C, Pollevick GD, Cordeiro JM, et al.: Loss-offunction mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007, 115:442\u2013449.","journal-title":"Circulation"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/CIRCULATIONAHA.106.627489","volume":"114","author":"J.M. Cordeiro","year":"2006","unstructured":"Cordeiro JM, Barajas-Martinez H, Hong K, et al.: Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome. Circulation 2006, 114:2026\u20132033.","journal-title":"Circulation"},{"key":"60_CR19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1540-8159.2006.00507.x","volume":"29","author":"C. Antzelevitch","year":"2006","unstructured":"Antzelevitch C: Brugada syndrome. Pacing Clin Electrophysiol 2006, 29:1130\u20131159.","journal-title":"Pacing Clin Electrophysiol"},{"key":"60_CR20","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/CIRCULATIONAHA.106.664219","volume":"115","author":"V. Probst","year":"2007","unstructured":"Probst V, Denjoy I, Meregalli PG, et al.: Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007, 115:2042\u20132048.","journal-title":"Circulation"},{"key":"60_CR21","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.107.746495","volume":"117","author":"M.J. Junttila","year":"2008","unstructured":"Junttila MJ, Gonzalez M, Lizotte E, et al.: Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation 2008, 117:1890\u20131893.","journal-title":"Circulation"},{"key":"60_CR22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.hrthm.2004.11.025","volume":"2","author":"C. Wolpert","year":"2005","unstructured":"Wolpert C, Echternach C, Veltmann C, et al.: Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm 2005, 2:254\u2013260.","journal-title":"Heart Rhythm"},{"key":"60_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijcard.2003.04.032","volume":"95","author":"S. Peters","year":"2004","unstructured":"Peters S, Trummel M, Denecke S, et al.: Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy. Int J Cardiol 2004, 95:207\u2013210.","journal-title":"Int J Cardiol"},{"key":"60_CR24","first-page":"285","volume":"112","author":"S.G. Priori","year":"2005","unstructured":"Priori SG, Napolitano C: Management of patients with Brugada syndrome should not be based on programmed electrical stimulation. Circulation 2005, 112:285\u2013291.","journal-title":"Circulation"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/europace\/eul087","volume":"8","author":"M. Abello","year":"2006","unstructured":"Abello M, Merino JL, Peinado R, et al.: Negative flecainide test in Brugada syndrome patients with previous positive response. Europace 2006, 8:899\u2013900.","journal-title":"Europace"},{"key":"60_CR26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1540-8167.2000.tb00334.x","volume":"11","author":"W. Shimizu","year":"2000","unstructured":"Shimizu W, Matsuo K, Takagi M, et al.: Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 2000, 11:396\u2013404.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjcard.2006.07.062","volume":"99","author":"K. Miyamoto","year":"2007","unstructured":"Miyamoto K, Yokokawa M, Tanaka K, et al.: Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome. Am J Cardiol 2007, 99:53\u201357.","journal-title":"Am J Cardiol"},{"key":"60_CR28","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1253\/circj.69.1064","volume":"69","author":"S.C. Shin","year":"2005","unstructured":"Shin SC, Ryu S, Lee JH, et al.: Prevalence of the Brugada-type ECG recorded from higher intercostal spaces in healthy Korean males. Circ J 2005, 69:1064\u20131067.","journal-title":"Circ J"},{"key":"60_CR29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.97.5.457","volume":"97","author":"J. Brugada","year":"1998","unstructured":"Brugada J, Brugada R, Brugada P: Right bundle-branch block and ST-segment elevation in leads V1 through V3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998, 97:457\u2013460.","journal-title":"Circulation"},{"key":"60_CR30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.104.485326","volume":"112","author":"P. Brugada","year":"2005","unstructured":"Brugada P, Brugada R, Brugada J: Patients with an asymptomatic Brugada electrocardiogram should undergo pharmacological and electrophysical testing. Circulation 2005, 112:279\u2013285.","journal-title":"Circulation"},{"key":"60_CR31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/CIRCULATIONAHA.104.485326","volume":"112","author":"P. Brugada","year":"2005","unstructured":"Brugada P, Brugada R, Brugada J: Response to Priori and Napolitano. Circulation 2005, 112:292.","journal-title":"Circulation"},{"key":"60_CR32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.0000153267.21278.8D","volume":"111","author":"L. Eckardt","year":"2005","unstructured":"Eckardt L, Probst V, Smits JP, et al.: Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada Syndrome. Circulation 2005, 111:257\u2013263.","journal-title":"Circulation"},{"key":"60_CR33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1540-8167.2006.00455.x","volume":"17","author":"A.K. Gehi","year":"2006","unstructured":"Gehi AK, Duong TD, Metz LD, et al.: Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis. J Cardiovasc Electrophysiol 2006, 17:577\u2013583.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR34","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1253\/circj.71.1437","volume":"71","author":"K. Ohkubo","year":"2007","unstructured":"Ohkubo K, Watanabe I, Takagi Y, et al.: Electrocardiographic and electrophysiologic characteristics in patients with Brugada type electrocardiogram and inducible ventricular fibrillation. Circ J 2007, 71:1437\u20131441.","journal-title":"Circ J"},{"key":"60_CR35","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/eurheartj\/ehm116","volume":"28","author":"M. Paul","year":"2007","unstructured":"Paul M, Gerss J, Schulze-Bahr E, et al.: Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J 2007, 28:2126\u20132133.","journal-title":"Eur Heart J"},{"key":"60_CR36","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","volume":"100","author":"G.X. Yan","year":"1999","unstructured":"Yan GX, Antzelevitch C: Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 1999, 100:1660\u20131666.","journal-title":"Circulation"},{"key":"60_CR37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.hrthm.2004.03.061","volume":"1","author":"J.M. Fish","year":"2004","unstructured":"Fish JM, Antzelevitch C: Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 2004, 1:210\u2013217.","journal-title":"Heart Rhythm"},{"key":"60_CR38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1540-8167.2007.01025.x","volume":"19","author":"J.M. Fish","year":"2008","unstructured":"Fish JM, Antzelevitch C: Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome. J Cardiovasc Electrophysiol 2008, 19:301\u2013308.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1460-9592.2001.00247.x","volume":"24","author":"J. Carlsson","year":"2001","unstructured":"Carlsson J, Erdogan A, Schulte B, et al.: Possible role of epicardial left ventricular programmed stimulation in Brugada syndrome. Pacing Clin Electrophysiol 2001, 24:247\u2013249.","journal-title":"Pacing Clin Electrophysiol"},{"key":"60_CR40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1540-8167.2007.01050.x","volume":"19","author":"M.J. Junttila","year":"2008","unstructured":"Junttila MJ, Brugada P, Hong K, et al.: Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients. J Cardiovasc Electrophysiol 2008, 19:380\u2013383.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1540-8167.2006.00531.x","volume":"17","author":"P.G. Meregalli","year":"2006","unstructured":"Meregalli PG, Ruijter JM, Hofman N, et al.: Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 2006, 17:857\u2013864.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/eurheartj\/ehl450","volume":"28","author":"A. Sarkozy","year":"2007","unstructured":"Sarkozy A, Boussy T, Kourgiannides G, et al.: Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J 2007, 28:334\u2013344.","journal-title":"Eur Heart J"},{"key":"60_CR43","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.106.628537","volume":"114","author":"F. Sacher","year":"2006","unstructured":"Sacher F, Probst V, Iesaka Y, et al.: Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation 2006, 114:2317\u20132324.","journal-title":"Circulation"},{"key":"60_CR44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ehj.2004.01.004","volume":"25","author":"P. Bordachar","year":"2004","unstructured":"Bordachar P, Reuter S, Garrigue S, et al.: Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J 2004, 25:879\u2013884.","journal-title":"Eur Heart J"},{"key":"60_CR45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2007.10.062","volume":"51","author":"J. Francis","year":"2008","unstructured":"Francis J, Antzelevitch C: Atrial fibrillation and Brugada syndrome. J Am Coll Cardiol 2008, 51:1149\u20131153.","journal-title":"J Am Coll Cardiol"},{"key":"60_CR46","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/europace\/eum110","volume":"1","author":"M.A. Babai Bigi","year":"2007","unstructured":"Babai Bigi MA, Aslani A, Shahrzad S: Clinical predictors of atrial fibrillation in Brugada syndrome. Europace 2007, 1:947\u2013950.","journal-title":"Europace"},{"key":"60_CR47","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacc.2007.10.060","volume":"51","author":"K.F. Kusano","year":"2008","unstructured":"Kusano KF, Taniyama M, Nakamura K, et al.: Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol 2008, 51:1169\u20131175.","journal-title":"J Am Coll Cardiol"},{"key":"60_CR48","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/CIRCULATIONAHA.106.686758","volume":"115","author":"S. Viskin","year":"2007","unstructured":"Viskin S: Brugada syndrome in children: don\u2019t ask, don\u2019t tell? Circulation 2007, 115:1970\u20131972.","journal-title":"Circulation"},{"key":"60_CR49","volume-title":"The Brugada Syndrome","author":"C. Antzelevitch","year":"1999","unstructured":"Antzelevitch C, Brugada P, Brugada J, et al.: The Brugada Syndrome. Armonk, NY: Futura Publishing Company; 1999. [Clinical Approaches to Tachyarrhythmias Series, #10.]"},{"key":"60_CR50","first-page":"202","volume-title":"The Brugada Syndrome: From Bench to Bedside","author":"B. Belhassen","year":"2004","unstructured":"Belhassen B, Viskin S: Pharmacologic approach to therapy of Brugada syndrome: quinidine as an alternative to ICD therapy? In The Brugada Syndrome: From Bench to Bedside. Edited by Antzelevitch C, Brugada P, Brugada J, Brugada R. Oxford: Blackwell Futura; 2004:202\u2013211."},{"key":"60_CR51","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.hrthm.2007.02.014","volume":"4","author":"T. Ohgo","year":"2007","unstructured":"Ohgo T, Okamura H, Noda T, et al.: Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 2007, 4:695\u2013700.","journal-title":"Heart Rhythm"},{"key":"60_CR52","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tips.2003.10.002","volume":"24","author":"L. Belardinelli","year":"2003","unstructured":"Belardinelli L, Antzelevitch C, Vos MA: Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci 2003, 24:619\u2013625.","journal-title":"Trends Pharmacol Sci"},{"key":"60_CR53","doi-asserted-by":"crossref","first-page":"iv4","DOI":"10.1093\/europace\/eum166","volume":"9","author":"C. Antzelevitch","year":"2007","unstructured":"Antzelevitch C: Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Europace 2007, 9:iv4\u2013iv15.","journal-title":"Europace"},{"key":"60_CR54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1540-8167.2006.00681.x","volume":"18","author":"M. Marquez","year":"2007","unstructured":"Marquez M, Salica G, Hermosillo AG, et al.: Ionic basis of pharmacological therapy in Brugada syndrome. J Cardiovasc Electrophysiol 2007, 18:234\u2013240.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR55","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1540-8167.2002.00698.x","volume":"13","author":"T. Tsuchiya","year":"2002","unstructured":"Tsuchiya T, Ashikaga K, Honda T, et al.: Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002, 13:698\u2013701.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR56","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00000542-200403000-00005","volume":"100","author":"P. Sergeev","year":"2004","unstructured":"Sergeev P, da Silva R, Lucchinetti E, et al.: Trigger-dependent gene expression profiles in cardiac preconditioning: evidence for distinct genetic programs in ischemic and anesthetic preconditioning. Anesthesiology 2004, 100:474\u2013488.","journal-title":"Anesthesiology"},{"key":"60_CR57","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1540-8167.2005.00290.x","volume":"17","author":"A. Abud","year":"2006","unstructured":"Abud A, Bagattin D, Goyeneche R, et al.: Failure of cilostazol in the prevention of ventricular fibrillation in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2006, 17:210\u2013212.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR58","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.105.601690","volume":"113","author":"J.M. Fish","year":"2006","unstructured":"Fish JM, Welchons DR, Kim YS, et al.: Dimethyl lithospermate B, an extract of danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 2006, 113:1393\u20131400.","journal-title":"Circulation"},{"key":"60_CR59","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","volume":"108","author":"M. Haissaguerre","year":"2003","unstructured":"Haissaguerre M, Extramiana F, Hocini M, et al.: Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation 2003, 108:925\u2013928.","journal-title":"Circulation"},{"key":"60_CR60","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0002-9149(00)01351-5","volume":"86","author":"H. Kataoka","year":"2000","unstructured":"Kataoka H: Electrocardiographic patterns of the Brugada syndrome in right ventricular infarction\/ischemia. Am J Cardiol 2000, 86:1056.","journal-title":"Am J Cardiol"},{"key":"60_CR61","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1056\/NEJMra022580","volume":"349","author":"K. Wang","year":"2003","unstructured":"Wang K, Asinger RW, Marriott HJ: ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 2003, 349:2128\u20132135.","journal-title":"N Engl J Med"},{"key":"60_CR62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.CIR.2.1.75","volume":"2","author":"G.B. Myers","year":"1950","unstructured":"Myers GB: Other QRS-T patterns that may be mistaken for myocardial infarction. IV. Alterations in blood potassium; myocardial ischemia; subepicardial myocarditis; distortion associated with arrhythmias. Circulation 1950, 2:75\u201393.","journal-title":"Circulation"},{"key":"60_CR63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0300-9572(02)00210-1","volume":"55","author":"J. Ortega-Carnicer","year":"2002","unstructured":"Ortega-Carnicer J, Benezet J, Ruiz-Lorenzo F, et al.: Transient Brugada-type electrocardiographic abnormalities in renal failure reversed by dialysis. Resuscitation 2002, 55:215\u2013219.","journal-title":"Resuscitation"},{"key":"60_CR64","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-9149(84)90274-1","volume":"54","author":"P.S. Douglas","year":"1984","unstructured":"Douglas PS, Carmichael KA, Palevsky PM: Extreme hypercalcemia and electrocardiographic changes. Am J Cardiol 1984, 54:674\u2013675.","journal-title":"Am J Cardiol"},{"key":"60_CR65","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/0002-9149(84)90273-X","volume":"54","author":"M.R. Sridharan","year":"1984","unstructured":"Sridharan MR, Horan LG: Electrocardiographic J wave of hypercalcemia. Am J Cardiol 1984, 54:672\u2013673.","journal-title":"Am J Cardiol"},{"key":"60_CR66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.carpath.2005.03.008","volume":"14","author":"G. Thiene","year":"2005","unstructured":"Thiene G, Basso C, Calabrese F, et al.: Twenty years of progress and beckoning frontiers in cardiovascular pathology. Cardiovasc Pathol 2005, 14:165\u2013169.","journal-title":"Cardiovasc Pathol"},{"key":"60_CR67","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1161\/01.CIR.0000144299.17008.07","volume":"110","author":"K. Hong","year":"2004","unstructured":"Hong K, Brugada J, Oliva A, et al.: Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004, 110:3023\u20133027.","journal-title":"Circulation"},{"key":"60_CR68","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.CIR.103.5.710","volume":"103","author":"D. Corrado","year":"2001","unstructured":"Corrado D, Basso C, Buja G, et al.: Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation 2001, 103:710\u2013717.","journal-title":"Circulation"},{"key":"60_CR69","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0735-1097(95)00485-8","volume":"27","author":"D. Corrado","year":"1996","unstructured":"Corrado D, Nava A, Buja G, et al.: Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996, 27:443\u2013448.","journal-title":"J Am Coll Cardiol"},{"key":"60_CR70","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.1976.03260300039030","volume":"235","author":"J.A. Abbott","year":"1976","unstructured":"Abbott JA, Cheitlin MD: The nonspecific camel-hump sign. JAMA 1976, 235:413\u2013414.","journal-title":"JAMA"},{"key":"60_CR71","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.CIR.23.6.853","volume":"23","author":"C. Hersch","year":"1961","unstructured":"Hersch C: Electrocardiographic changes in head injuries. Circulation 1961, 23:853\u2013860.","journal-title":"Circulation"},{"key":"60_CR72","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1540-8159.1999.tb00613.x","volume":"22","author":"N. Tarin","year":"1999","unstructured":"Tarin N, Farre J, Rubio JM, et al.: Brugada-like electrocardiographic pattern in a patient with a mediastinal tumor. Pacing Clin Electrophysiol 1999, 22:1264\u20131266.","journal-title":"Pacing Clin Electrophysiol"},{"key":"60_CR73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1253\/circj.67.8","volume":"67","author":"H. Atarashi","year":"2003","unstructured":"Atarashi H, Ogawa S: New ECG criteria for high-risk Brugada syndrome. Circ J 2003, 67:8\u201310.","journal-title":"Circ J"},{"key":"60_CR74","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1253\/circj.67.312","volume":"67","author":"H. Morita","year":"2003","unstructured":"Morita H, Takenaka-Morita S, Fukushima-Kusano K, et al.: Risk stratification for asymptomatic patients with Brugada syndrome. Circ J 2003, 67:312\u2013316.","journal-title":"Circ J"},{"key":"60_CR75","first-page":"73","volume":"7","author":"M. Takagi","year":"2007","unstructured":"Takagi M, Tatsumi H, Yoshiyama M: Approach to the asymptomatic patients with Brugada syndrome. Indian Pacing Electrophysiol J 2007, 7:73\u201376.","journal-title":"Indian Pacing Electrophysiol J"},{"key":"60_CR76","unstructured":"Bigi MA, Aslani A, Aslani A: Significance of cardiac autonomic neuropathy in risk stratification of Brugada syndrome. Europace 2007 Dec 18 (Epub ahead of print)."},{"key":"60_CR77","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jacc.2005.12.049","volume":"47","author":"J. Castro Hevia","year":"2006","unstructured":"Castro Hevia J, Antzelevitch C, Torn\u00e9s B\u00e1rzaga F, et al.: Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia\/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 2006, 47:1828\u20131834.","journal-title":"J Am Coll Cardiol"},{"key":"60_CR78","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1540-8167.2004.40411.x","volume":"16","author":"M. Nishizaki","year":"2005","unstructured":"Nishizaki M, Fujii H, Sakurada H, et al.: Spontaneous T wave alternans in a patient with Brugada syndrome-responses to intravenous administration of class I antiarrhythmic drug, glucose tolerance test, and atrial pacing. J Cardiovasc Electrophysiol 2005, 16:217\u2013220.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR79","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1540-8159.2000.tb06773.x","volume":"23","author":"H. Tada","year":"2000","unstructured":"Tada H, Nogami A, Shimizu W, et al.: ST segment and T wave alternans in a patient with Brugada syndrome. Pacing Clin Electrophysiol 2000, 23:413\u2013415.","journal-title":"Pacing Clin Electrophysiol"},{"key":"60_CR80","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1540-8167.2001.00493.x","volume":"12","author":"M. Chinushi","year":"2001","unstructured":"Chinushi M, Washizuka T, Okumura H, et al.: Intravenous administration of class I antiarrhythmic drugs induced T wave alternans in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2001, 12:493\u2013495.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1540-8167.2002.00191.x","volume":"13","author":"Y. Chinushi","year":"2002","unstructured":"Chinushi Y, Chinushi M, Toida T, et al.: Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina. J Cardiovasc Electrophysiol 2002, 13:191\u2013194.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR82","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1540-8167.2002.00837.x","volume":"13","author":"M. Takagi","year":"2002","unstructured":"Takagi M, Doi A, Takeuchi K, et al.: Pilsicanide-induced marked T wave alternans and ventricular fibrillation in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002, 13:837.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR83","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1046\/j.1460-9592.2003.00288.x","volume":"26","author":"K. Ohkubo","year":"2003","unstructured":"Ohkubo K, Watanabe I, Okumura Y, et al.: Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient. Pacing Clin Electrophysiol 2003, 26:1900\u20131903.","journal-title":"Pacing Clin Electrophysiol"},{"key":"60_CR84","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jacc.2003.06.004","volume":"42","author":"H. Morita","year":"2003","unstructured":"Morita H, Morita ST, Nagase S, et al.: Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 2003, 42:1624\u20131631.","journal-title":"J Am Coll Cardiol"},{"key":"60_CR85","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1540-8167.2002.00816.x","volume":"13","author":"H. Morita","year":"2002","unstructured":"Morita H, Nagase S, Kusano K, et al.: Spontaneous T wave alternans and premature ventricular contractions during febrile illness in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002, 13:816\u2013818.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR86","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1540-8167.2008.01148.x","volume":"19","author":"T. Tada","year":"2008","unstructured":"Tada T, Kusano KF, Nagase S, et al.: Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2008, 19:56\u201361.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"60_CR87","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.hrthm.2007.04.017","volume":"4","author":"M.A. Babai Bigi","year":"2007","unstructured":"Babai Bigi MA, Aslani A, Shahrzad S: aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome. Heart Rhythm 2007, 4:1009\u20131012.","journal-title":"Heart Rhythm"},{"key":"60_CR88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hrthm.2007.09.013","volume":"5","author":"M.A. Babaee Bigi","year":"2008","unstructured":"Babaee Bigi MA, Moaref AR, Aslani A: Interventricular mechanical dyssynchrony: a novel marker of cardiac events in Brugada syndrome. Heart Rhythm 2008, 5:79\u201382.","journal-title":"Heart Rhythm"},{"key":"60_CR89","first-page":"2260","volume":"118","author":"H. Watanabe","year":"2008","unstructured":"Watanabe H, Koopmann TT, Le Scouarnec S, et al.: Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 2008, 118:2260\u20132268.","journal-title":"J Clin Invest"},{"key":"60_CR90","doi-asserted-by":"crossref","unstructured":"Delp\u00f3n E, Cordeiro JM, N\u00fa\u00f1ez L, et al.: Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circulation Arrhythmia and Electrophysiology 2008 (in press).","DOI":"10.1161\/CIRCEP.107.748103"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-008-0060-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-008-0060-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-008-0060-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:56:09Z","timestamp":1559418969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-008-0060-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s11886-008-0060-y","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}